Sinonasal microbiome remains stable during dupilumab therapy in chronic rhinosinusitis: a pilot study. Hirsch T, Moser U, Wolf A, Andrianakis A, et al. Eur Arch Otorhinolaryngol 2026;283:6807-6814.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hirsch T, Moser U, Wolf A, Andrianakis A, et al. Sinonasal microbiome remains stable during dupilumab therapy in chronic rhinosinusitis: a pilot study. Eur Arch Otorhinolaryngol 2026;283:6807-6814.
PMID: 42289567